» Articles » PMID: 34299213

The MEK5/ERK5 Pathway in Health and Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jul 24
PMID 34299213
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The MEK5/ERK5 mitogen-activated protein kinases (MAPK) cascade is a unique signaling module activated by both mitogens and stress stimuli, including cytokines, fluid shear stress, high osmolarity, and oxidative stress. Physiologically, it is mainly known as a mechanoreceptive pathway in the endothelium, where it transduces the various vasoprotective effects of laminar blood flow. However, it also maintains integrity in other tissues exposed to mechanical stress, including bone, cartilage, and muscle, where it exerts a key function as a survival and differentiation pathway. Beyond its diverse physiological roles, the MEK5/ERK5 pathway has also been implicated in various diseases, including cancer, where it has recently emerged as a major escape route, sustaining tumor cell survival and proliferation under drug stress. In addition, MEK5/ERK5 dysfunction may foster cardiovascular diseases such as atherosclerosis. Here, we highlight the importance of the MEK5/ERK5 pathway in health and disease, focusing on its role as a protective cascade in mechanical stress-exposed healthy tissues and its function as a therapy resistance pathway in cancers. We discuss the perspective of targeting this cascade for cancer treatment and weigh its chances and potential risks when considering its emerging role as a protective stress response pathway.

Citing Articles

Equal performance of HTK-based and UW-based perfusion solutions in sub-normothermic liver machine perfusion.

Leber B, Stimmeder S, Briendl K, Weber J, Rohrhofer L, Aigelsreiter A Sci Rep. 2025; 15(1):7601.

PMID: 40038333 PMC: 11880568. DOI: 10.1038/s41598-025-90799-2.


Mapk7 enhances osteogenesis and suppresses adipogenesis by activating Lrp6/β-catenin signaling axis in mesenchymal stem cells.

Li C, Long J, Chen S, Tian L, Xiao Y, Chen S Commun Biol. 2025; 8(1):310.

PMID: 40000807 PMC: 11861680. DOI: 10.1038/s42003-025-07765-x.


MEK5-ERK5 pathway mediates mitophagy by regulating Nur77 to promote tumorigenesis of osteosarcoma cells.

Wang J, Xue J, Ma B, Zhu Y, Li J, Tian C Eur J Med Res. 2025; 30(1):117.

PMID: 39972514 PMC: 11837295. DOI: 10.1186/s40001-025-02312-0.


Investigation of compounds as ERK5 inhibitor related to breast cancer via molecular docking and dynamic simulation.

Ottu P, Babalola O, Oluwamodupe C, Oluwatobiloba A, Kehinde I, Akinola O In Silico Pharmacol. 2025; 13(1):18.

PMID: 39872469 PMC: 11762040. DOI: 10.1007/s40203-025-00304-w.


Unravelling the Mechanisms of Oxidised Low-Density Lipoprotein in Cardiovascular Health: Current Evidence from In Vitro and In Vivo Studies.

Thangasparan S, Kamisah Y, Ugusman A, Anuar N, Ibrahim N Int J Mol Sci. 2025; 25(24.

PMID: 39769058 PMC: 11676878. DOI: 10.3390/ijms252413292.


References
1.
Schiaffino S, Reggiani C, Akimoto T, Blaauw B . Molecular Mechanisms of Skeletal Muscle Hypertrophy. J Neuromuscul Dis. 2020; 8(2):169-183. PMC: 8075408. DOI: 10.3233/JND-200568. View

2.
Zhuang K, Zhang J, Xiong M, Wang X, Luo X, Han L . CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis. Cell Death Dis. 2016; 7(10):e2415. PMC: 5133995. DOI: 10.1038/cddis.2016.333. View

3.
Zhou Z, Tang A, Wong W, Bamezai S, Goddard L, Shenkar R . Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature. 2016; 532(7597):122-6. PMC: 4864035. DOI: 10.1038/nature17178. View

4.
Pearson A, Fullwood P, Toro Tapia G, Prise I, Smith M, Xu Q . Discovery of a Gatekeeper Residue in the C-Terminal Tail of the Extracellular Signal-Regulated Protein Kinase 5 (ERK5). Int J Mol Sci. 2020; 21(3). PMC: 7037328. DOI: 10.3390/ijms21030929. View

5.
Zhou G, Hamik A, Nayak L, Tian H, Shi H, Lu Y . Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J Clin Invest. 2012; 122(12):4727-31. PMC: 3533563. DOI: 10.1172/JCI66056. View